Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Stephen L. Rawlings

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-196 properties)
Infobox
Patent primary examiner of
‌
US Patent 7087405 Nucleic acids encoding anti-human ανβ3 and ανβ5 antibodies
‌
US Patent 7087715 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
‌
US Patent 7094873 Polypeptide that interacts with heat shock proteins
‌
US Patent 7098306 Method and compositions for treating hepatocellular cancer
‌
US Patent 7112419 Human hepatoma associated protein and the polynucleotide encoding said polypeptide
‌
US Patent 7118876 Altered intracellular localization of BRK/Sik protein tyrosine kinase in human prostate tumors
‌
US Patent 7118912 Methods and compositions for categorizing patients
‌
US Patent 7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
‌
US Patent 7135333 Compositions that specifically bind to colorectal cancer cells and methods of using the same
‌
US Patent 7144991 Streptavidin expressed gene fusions and methods of use thereof
‌
US Patent 7148038 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
‌
US Patent 7157087 Enhancement of intracellular delivery and tissue targeting of drugs and genes
‌
US Patent 7160681 Method for regulating cell growth and assays related thereto
‌
US Patent 7172880 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
‌
US Patent 7176291 Glycine N-methyltransferase monoclonal antibodies and methods of use therefor
‌
US Patent 7183076 Method for making multispecific antibodies having heteromultimeric and common components
‌
US Patent 7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
‌
US Patent 7189823 Antibody against illfdyfnr
‌
US Patent 7192769 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
‌
US Patent 7198899 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
‌
US Patent 7214782 Nucleic acid of novel human kinesin-related gene protein encoded by the nucleic acid peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
‌
US Patent 7217532 Methods for detecting DNA damage and screening for cancer therapeutics
‌
US Patent 7226596 Compositions and methods for the treatment of tumors
‌
US Patent 7226750 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
‌
US Patent 7235643 Antibodies and methods for generating genetically altered antibodies with high affinity
‌
US Patent 7238525 Strategy for leukemia therapy
‌
US Patent 7247473 Motor proteins and methods for their use
‌
US Patent 7247476 Individualized anti-cancer antibodies
‌
US Patent 7247718 Antibody recognizing a small subset of human hematopoietic cells
‌
US Patent 7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis
‌
US Patent 7264967 Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding
‌
US Patent 7276372 Antibodies against GPR64 and uses thereof
‌
US Patent 7279294 Tumor markers in ovarian cancer
‌
US Patent 7279556 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
‌
US Patent 7303914 Monoclonal antibody against human hepatoma and use thereof
‌
US Patent 7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein
‌
US Patent 7306926 Method for detecting carcinomas in a solubilized cervical body sample
‌
US Patent 7312305 Tumor cytotoxicity induced by modulators of the CXCR4 receptor
‌
US Patent 7314855 Inhibition of ATF2 activity to treat cancer
‌
US Patent 7316902 Compositions that specifically bind to colorectal cancer cells and methods of using the same
‌
US Patent 7317089 Antagonistic anti-hTNFSF13b human antibodies
‌
US Patent 7329502 ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
‌
US Patent 7329729 Secreted epithelial colon stromal-1 molecules and uses thereof
‌
US Patent 7329745 Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
‌
US Patent 7335744 Prostate cancer specific internalizing human antibodies
‌
US Patent 7338758 Compositions and methods for the identification, assessment, prevention and therapy of human cancers
‌
US Patent 7339047 Caspase-8 interacting proteins
‌
US Patent 7342094 Tumor vaccines for MUC1-positive carcinomas
‌
US Patent 7342105 Antibody and use thereof
‌
US Patent 7351810 Polypeptides, polynucleotides and uses thereof
‌
US Patent 7351816 Nucleic acid encoding anti-IgE antibodies
‌
US Patent 7354709 Collapsin response mediator protein-1
‌
US Patent 7355025 Marker molecules associated with lung tumors
‌
US Patent 7361474 Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
‌
US Patent 7361511 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
‌
US Patent 11179450 Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells
‌
US Patent 11180563 FLT3 binding proteins and methods of use
‌
US Patent 11180570 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use
‌
US Patent 7365167 Humanized collagen antibodies and related methods
‌
US Patent 7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
‌
US Patent 7371840 Isolation and characterization of
‌
US Patent 7374886 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
‌
US Patent 7387895 Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
‌
US Patent 7390885 Humanized collagen antibodies and related methods
‌
US Patent 7396915 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent
‌
US Patent 7405290 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
‌
US Patent 7408041 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
‌
US Patent 7420040 Cytotoxicity mediation of cells evidencing surface expression of TROP-2
‌
US Patent 7420041 Cytotoxicity mediation of cells evidencing surface expression of TROP-2
‌
US Patent 7422899 Antibodies to the human prolactin receptor
‌
US Patent 7442543 Mammalian selenoprotein differentially expressed in tumor cells
‌
US Patent 7456016 Cancerous disease modifying antibodies
‌
US Patent 7459538 Recombinant tumor specific antibody and use thereof
‌
US Patent 7470509 Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
‌
US Patent 7473561 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
‌
US Patent 7476506 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
‌
US Patent 7476535 TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes
‌
US Patent 7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
‌
US Patent 7517662 Method for solution based diagnosis
‌
US Patent 7521205 Genes and polypeptides relating to prostate cancers
‌
US Patent 7541035 Immunogenic peptides for the treatment of prostate and breast cancer
‌
US Patent 7541441 Antibodies that specifically bind to TL5
‌
US Patent 7547517 MAGE-C2 antigenic peptides and uses thereof
‌
US Patent 7547544 Antibodies against GPR64 and uses thereof
‌
US Patent 7547759 Induction of tumor immunity by variants of folate binding protein
‌
US Patent 7560230 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
‌
US Patent 7569356 Diagnosis and therapy of cancer using SGP28-related molecules
‌
US Patent 7576187 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
‌
US Patent 7582736 Prostate cancer specific internalizing human antibodies
‌
US Patent 7585505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
‌
US Patent 7585939 Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes
‌
US Patent 7589180 Specific binding proteins and uses thereof
‌
US Patent 7592143 Methods of treating diseases responsive to induction of apoptosis and screening assays
‌
US Patent 7598353 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
‌
US Patent 7605237 High affinity human antibodies to human IL-4 receptor
‌
US Patent 7608693 High affinity human antibodies to human IL-4 receptor
‌
US Patent 7615623 BAG proteins and nucleic acid molecules encoding them
‌
US Patent 7629144 Secreted epithelial colon stromal-1 molecules and uses thereof
‌
US Patent 7629439 Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy
‌
US Patent 7632924 Antigen-binding polypeptides and their uses
‌
US Patent 7655234 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
‌
US Patent 7655402 Diagnoses and therapeutics for cancer
‌
US Patent 7655471 Biochemical markers of the human endometrium
‌
US Patent 7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
‌
US Patent 7658935 Methods and compositions for stimulating the immune system
‌
US Patent 7659117 Compositions and methods for dendritic cell-based immunotherapy
‌
US Patent 7666425 Treatment and diagnosis of prostate cancer
‌
US Patent 7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
‌
US Patent 7666984 Tumour-associated peptides binding to MHC-molecules
‌
US Patent 7666997 Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
‌
US Patent 7667004 Humanized antibodies against vascular endothelial growth factor
‌
US Patent 7667014 Method of detecting the expression of PPN/MG61 and the use of it
‌
US Patent 7667015 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
‌
US Patent 7671179 Antibodies and methods for generating genetically altered antibodies with high affinity
‌
US Patent 7674605 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
‌
US Patent 7691376 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
‌
US Patent 7700742 Antibodies to insulin-like growth factor I receptor
‌
US Patent 7709000 Antibody recognizing a small subset of human hematopoietic cells
‌
US Patent 7709252 Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
‌
US Patent 7714110 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
‌
US Patent 7714113 Fusion proteins of humanized g250 specific antibodies and uses thereof
‌
US Patent 7723472 Extracellular matrix binding chimeric proteins and methods of use thereof
‌
US Patent 7723501 Bag proteins and nucleic acid molecules encoding them
‌
US Patent 7728109 Antagonistic anti-hTNFSF13b human antibodies
‌
US Patent 7732576 Tumor suppressor designated TS10Q23.3
‌
US Patent 7741111 Pregnancy, up-regulated non-ubiquitous CaM kinase
‌
US Patent 7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
‌
US Patent 7745149 Tumor markers for ovarian cancer diagnosis
‌
US Patent 7745584 Antibodies to sulfated carbohydrates
‌
US Patent 7763247 Humanized collagen antibodies and related methods
‌
US Patent 7763248 Humanized collagen antibodies and related methods
‌
US Patent 7763438 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
‌
US Patent 7771965 Tumor endothelial marker 5α molecules and uses thereof
‌
US Patent 7776607 Mammalian selenoprotein differentially expressed in tumor cells
‌
US Patent 7781212 Antitumor antibodies, proteins, and uses thereof
‌
US Patent 7781413 SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
‌
US Patent 7781568 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
‌
US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof
‌
US Patent 7786270 Humanized FcγRIIB-specific antibodies and methods of use thereof
‌
US Patent 7794717 High affinity human antibodies to human IL-4 receptor
‌
US Patent 7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
‌
US Patent 7799900 Immunoglobulin variants and uses thereof
‌
US Patent 7803618 Recombinant tumor specific antibody and use thereof
‌
US Patent 7807163 Antibodies against GPR64 and uses thereof
‌
US Patent 7807373 Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer
‌
US Patent 7807416 Antibodies and methods for generating genetically altered antibodies with enhanced effector function
‌
US Patent 7811564 Prostate cancer diagnosis and treatment
‌
US Patent 7811568 Smallpox monoclonal antibody
‌
US Patent 7811789 Polypeptides, polynucleotides and uses thereof
‌
US Patent 7811984 BV8 nucleic acids and polypeptides with mitogenic activity
‌
US Patent 7812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses
‌
US Patent 7816493 Soluble form of carbonic anhydrase IX (S-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/NEU/C-ERBB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
‌
US Patent 7824681 Human monoclonal antibodies that specifically bind IGF-II
‌
US Patent 7824865 Method for examining WT1-related disease
‌
US Patent 7833526 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
‌
US Patent 7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
‌
US Patent 7838216 Human gene related to but distinct from EGF receptor gene
‌
US Patent 7838251 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
‌
US Patent 7838638 Anti-IL-17 antibodies
‌
US Patent 7842782 Heparanase-derived peptides for vaccination of tumor patients
‌
US Patent 7842790 Antibodies against human parathyroid hormone related protein
‌
US Patent 7846450 Melanoma associated peptide analogues and vaccines against melanoma
‌
US Patent 7846667 Methods for the diagnosis and treatment of lung cancer
‌
US Patent 7846673 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
‌
US Patent 7846737 Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
‌
US Patent 7847067 Antibodies to NTB-A
‌
US Patent 7850971 PSMA antibodies and protein multimers
‌
US Patent 7850981 Immuno-adjuvant PDT treatment of metastatic tumors
‌
US Patent 7851181 Neutralizing human anti-IGFR antibody
‌
US Patent 7858092 Neovascular-targeted immunoconjugates
‌
US Patent 7871775 Compositions and methods for the identification, assessment, prevention and therapy of human cancers
‌
US Patent 7875278 Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
‌
US Patent 7883896 Marker molecules associated with lung tumors
‌
US Patent 7887809 Neovascular-targeted immunoconjugates
‌
US Patent 7888463 Modulators of antiestrogen pharmacology
‌
US Patent 7892750 Cathepsin E as a marker of colon cancer
‌
US Patent 7892827 Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
‌
US Patent 7902339 Antitumor antibodies, proteins, and uses thereof
‌
US Patent 7910691 MN gene and protein
‌
US Patent 7910693 Prostate cancer diagnosis and treatment
‌
US Patent 7915000 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
‌
US Patent 7915390 Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
‌
US Patent 7919458 Method of inhibiting prostate cancer cell proliferation
‌
US Patent 7919606 Biological products
‌
US Patent 7923538 Recombinant antibody composition
‌
US Patent 7928190 Methods and compositions for tumor vaccination and therapy
‌
US Patent 7935525 Inhibition of ATF2 activity to treat cancer
‌
US Patent 7935791 Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
‌
US Patent 7947809 Compositions and methods relating to glucagon receptor antibodies
‌
US Patent 7956162 Cancer-associated antigen
‌
US Patent 7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
‌
US Patent 7981610 ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
‌
US Patent 7981628 Monoclonal antibodies and their use
‌
US Patent 7982015 Compositions and methods for treatment of cancer
‌
US Patent 7982016 Antigen binding proteins capable of binding thymic stromal lymphopoietin
‌
US Patent 8012935 Synthetic peptides and methods for treating cancer invasion and metastasis
Edits on 13 Dec, 2021
Golden AI profile picture
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8012935 Synthetic peptides and methods for treating cancer invasion and metastasis
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7982016 Antigen binding proteins capable of binding thymic stromal lymphopoietin
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7982015 Compositions and methods for treatment of cancer
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7981628 Monoclonal antibodies and their use
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7956162 Cancer-associated antigen
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7947809 Compositions and methods relating to glucagon receptor antibodies
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7935525 Inhibition of ATF2 activity to treat cancer
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7928190 Methods and compositions for tumor vaccination and therapy
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7923538 Recombinant antibody composition
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7919606 Biological products
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7919458 Method of inhibiting prostate cancer cell proliferation
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7915390 Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7910691 MN gene and protein
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7910693 Prostate cancer diagnosis and treatment
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7902339 Antitumor antibodies, proteins, and uses thereof

Find more people like Stephen L. Rawlings

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.